Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 1
A Phase 1b/2 Study of Abemaciclib Plus Cabozantinib in Immune Checkpoint Blockade-pretreated Metastatic Clear Cell Renal Cell Carcinoma
The researchers are doing this study to find out whether the combination of abemaciclib and cabozantinib is a safe and effective treatment for people with meta…
Metastatic Renal Cell CarcinomaTranslocation Renal Cell Carcinoma
Estimated
~$10 – $6,250
Memorial Sloan Kettering Cancer CenterNCT06835972
Phase 2
A Phase 2 Study of Sasanlimab, Palbociclib and Axitinib in Metastatic Renal Cell Carcinoma - SPARCC
The goal of this research study is to evaluate how well and safely the study drugs sasanlimab, palbociclib, and axitinib work for treatment of participants wit…
Metastatic Renal Cell CarcinomaMetastatic Renal CancerRenal Cell Carcinoma+3 more
Estimated
~$10 – $7,500
Stephanie BergNCT07123090